发明名称 Methods and compositions for the treatment of β-thalassemia
摘要 Methods and compositions for the treatment of β-thalassemia are provided. Methods and compositions restore or increase erythrocyte maturation in individuals afflicted with β-TM by preventing proteolysis of GATA-1 protein. Screening methods for identifying agents which bind heat shock protein 70 (HSP-70) and inhibit HSP-70 α-globin binding, but which allow GATA-1 protein-HSP-1 binding in a manner that prevents GATA-1 proteolysis.
申请公布号 US9377471(B2) 申请公布日期 2016.06.28
申请号 US201414547208 申请日期 2014.11.19
申请人 Institut National de la Sante et de la Recherche Medicale (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);Universite Paris Descartes—Paris V;Assistance Publique—Hopitaux de Paris;Fondation Imagine 发明人 Hermine Olivier;Courtois Genevieve;Arlet Jean-Benoit;Ribeil Jean-Antoine
分类号 G01N33/68;A61K38/16;G01N33/80 主分类号 G01N33/68
代理机构 Whitham, Curtis & Cook, P.C. 代理人 Whitham, Curtis & Cook, P.C.
主权项 1. A method of screening candidate compounds in order to select compounds which inhibit binding of α globin to Hsp70 but which do not inhibit binding of Hsp70 to GATA-1, comprising i) providing a plurality of candidate compounds which may inhibit binding of α globin to Hsp70; ii) exposing Hsp70 to said plurality of candidate compounds in the presence of α globin and under conditions which allow α globin to bind to Hsp70; iii) identifying Hsp-70-compound complexes which do not contain bound α globin; iv) exposing Hsp-70-compound complexes identified in said identifying step iii) to GATA-1 under conditions that permit Hsp70 to bind to GATA-1; v) identifying Hsp70-compound-GATA-1 complexes fowled in said exposing step iv); and vi) selecting compounds identified in said identifying step v) as compounds which inhibit binding of α globin to Hsp70 but which do not inhibit binding of Hsp70 to GATA-1.
地址 Paris FR